top of page

News about us

February 2024

QMB announces the appointment of John Brzezenski to its QMB QualiVerse Advisory Board Boston, MA, USA – February 11, 2024 

QMB, Inc., a tech startup developing an AI SaaS in the MedTech Regulatory sector, today announced that John Brzezinski had joined its strategic Advisory Board as it accelerates the development of its AI regulatory software platform QualiVerse. 

“John brings with him an extensive professional and VC network and has great functional/operational experience, allowing him to understand the requirements of getting a startup running and succeeding! We look forward to working with him closely as we continue our development efforts on QualiVerse & AI integration…”

Mr. Brzezenski has a lengthy history of consulting and working in the venture capital investment sector with a special focus on young emerging companies. Additionally, he has a broad-based background spanning operating/executive management, advisory, and private equity roles, helping numerous companies develop and execute successful growth strategies. Mr. Brzezenski has developed perspectives from “all sides of the table,” has been a Partner with a Strategy/Mergers and acquisitions advisory firm, a senior operating executive, and a member of the investment committee of a venture capital firm. Mr. Brzezenski is currently a Partner with J. Locke & Co., a merchant banking group, and a member and former Board Director of Launchpad Venture Group. Mr. Brzezenski graduated with honors from Harvard University with an BA in Economics and holds an MBA from the Kellogg School at Northwestern University.

 

Michel Moravia will be leading a session and panel at this year’s LSI Emerging MedTech Summit, LSI USA24. This meeEng brings together thought leaders and organizaEons in the world of Medical Device focused on delivering and innovaEng within the healthcare environment. A unique objecEve of this meeEng is to promote collaboraEon and partnering within the industry.

Michel Moravia leads the Northeastern University Evolve startups in a discussion about regulatory standards and quality

April 2024

Michel Moravia will be leading a regulatory workshop on February 27th at Evolve, a Northeastern University Accelerator focused on working with early-stage life science and healthcare ventures. “QMB understands the effort and dedication required to make startup ventures successful. We see such opportunities as a new way to reach out and collaborate with a new generation of innovators and disruptors in life sciences. We want to help them with their regulatory strategy and provide guidance so that they succeed…” 

April 10, 2024, Michel Moravia will be participating in a panel discussion on AI and its effect on biomedical regulation and policy at Harvard Law School

May 2024

QMB welcomes Dale Jones to their organization. Boston, MA, USA – May 5, 2024 – QMB, Inc. a leading Quality and Regulatory consulting firm and Tech Startup developing a disruptive AI-enabled Regulatory SaaS platform called QualiVerseä, welcomes Dale Jones as Principal Consultant. 

“Dale adds a tremendous amount of additional experience to the QMB consulting team. His background in quality and working for a wide range of organizations makes him a great versatile asset for all current and future clients of QMB.”

Mr. Dale Jones has a been working within the Quality Management sector for nearly seventeen years. He has held numerous quality focused roles within companies such as Thermo Fisher Scientific, Amazon Global Robotics, and Materion Corporation and has consulted with others such as Johnson & Johnson, Philips Healthcare, and LumiraDx. Dale is CMQ/OE certified, and additionally holds certifications in ISO 9001/13485. Dale obtained a BSc in Microbiology from University of Wisconsin-Oshkosh and a MSc in Bacteriology from University of WisconsinMadison.


 

bottom of page